1. FRI0428 The JAK1-selective inhibitor, filgotinib, inhibits inflammation pathways observed in an IL23-induced psoriatic arthritis mouse model. (15th June 2017) Authors: Blanqué, R; Ongenaert, M; David, C; Robin-Jagerschmidt, C; Cauvin, A; Saccomani, C; Clement-Lacroix, P; Dupont, S; Galien, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0161 The JAK1 selective inhibitor filgotinib regulates both enthesis and colon inflammation in a mouse model of psoriatic arthritis. (15th June 2017) Authors: Robin-Jagerschmidt, C; Lavazais, S; Marsais, F; Monjardet, A; Cauvin, A; Saccomani, C; Parent, I; Merciris, D; Chanudet, E; Borgonovi, M; Lepescheux, L; Auberval, M; Dupont, S; Clement-Lacroix, P; Galien, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0180 Pharmacological characterization of the ADAMTS-5 inhibitor GLPG1972: an oral anti-catabolic agent for the treatment of osteoarthritis. (15th June 2017) Authors: Clement-Lacroix, P; Little, C; Blanqué, R; Meurisse, S; Mollat, P; Brebion, F; Gosmini, R; Ceuninck, F De; Botez, I; Lepescheux, L; Aar, E van der; Christophe, T; Vandervoort, N; Cottereaux, C; Comas, D; Deprez, P; Amantini, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗